مؤتمر
AML-348 A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies
| العنوان: | AML-348 A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies |
|---|---|
| المؤلفون: | Lachowiez, C, Borthakur, G, Loghavi, S, Zeng, Z, Kadia, T, Masarova, L, Takahashi, K, Tippett, G, Garcia, J, Bose, P, Jabbour, E, Ravandi, F, Daver, N, Manero, GG, Vyas, P, Kantarjian, H, Konopleva, M, DiNardo, C |
| بيانات النشر: | Elsevier |
| سنة النشر: | 2022 |
| المجموعة: | Oxford University Research Archive (ORA) |
| نوع الوثيقة: | conference object |
| اللغة: | English |
| العلاقة: | https://ora.ox.ac.uk/objects/uuid:898935c3-b49d-4a1d-bba0-8605bcbc1fd1Test; https://doi.org/10.1016/S2152-2650Test(22)01276-9 |
| DOI: | 10.1016/S2152-2650(22)01276-9 |
| الإتاحة: | https://doi.org/10.1016/S2152-2650Test(22)01276-9 https://ora.ox.ac.uk/objects/uuid:898935c3-b49d-4a1d-bba0-8605bcbc1fd1Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.B9BD7FF7 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/S2152-2650(22)01276-9 |
|---|